Answers are grounded in this paper and cite their sources.
Background and aim Snake venom metalloproteinases (SVMPs) are abundant multidomain enzymes with diverse biological functions. This study aimed to purify and characterize a novel SVMP, CcVMP-III, from Cerastes cerastes venom and assess its protective effects in pulmonary embolism murine model.Experimental approach CcVMP-III (110 kDa) was purified by chromatographic techniques and partially sequenced using N-terminal and LC-MS/MS analyses. Biological activities were evaluated using coagulation parameters (aPTT, TT, PT), clot degradation, and fibrin plate lysis. Thromboprotective efficacy was assessed using a thrombin-induced pulmonary embolism model.Key findings CcVMP-III was identified as a class-III SVMP containing metalloproteinase, disintegrin-like, and cysteine-rich domains. It selectively prolonged aPTT and TT without affecting PT and exhibited strong fibrinolytic and thrombolytic activities. In vivo, it significantly prevented pulmonary thrombus formation, demonstrating marked thromboprotective efficacy.Conclusion These findings emphasize the potential of CcVMP-III as a promising thromboprotective agent that may mitigate morbidity and mortality associated with thromboembolic events.
No takes yet. Share an insight, caveat, or question.
Aouadi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: